# Eltrombopag With Decitabine in Advanced Myelodysplastic Syndrome (MDS)

> **NCT02010645** · PHASE2 · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 6 (actual)

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** Eltrombopag
- **DRUG:** Decitabine

## Key facts

- **NCT ID:** NCT02010645
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-03
- **Primary completion:** 2019-01-02
- **Final completion:** 2019-01-02
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** PI Request
- **Last updated:** 2020-01-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02010645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02010645, "Eltrombopag With Decitabine in Advanced Myelodysplastic Syndrome (MDS)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02010645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*